Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.

AAV cis -regulatory sequences are correlated with ocular toxicity

Open access

Abstract

Significance: Adeno-associated viral (AAV) gene therapy is becoming an important therapeutic modality, especially for ocular diseases, due to its efficiency of gene delivery and relative lack of pathogenicity. However, AAV sometimes can cause inflammation and toxicity. We explored such effects using injections into the mouse eye. We found a strong correlation of toxicity and inflammation with the use of promoters that were broadly active, or specifically active in the retinal pigment epithelium. AAVs with photoreceptor-specific promoters were found to be nontoxic at all doses tested. These studies reveal that safer vectors can be designed if assays for relevant and specific cell types are developed and tested with a range of vectors with different genomic elements.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1821000116

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Retina toxicity is induced by broadly active but not retinal cell-type-specific promoters. (A and B) Wild-type retinas of CD-1 mice were infected at P0 with the indicated viruses at either high (3E9 vg per eye) or low dose (8E8 vg per eye) and harvested at P30 for histology. Retinal cross-sections were stained for short- and medium/long-wavelength opsins (red) (A) and for GFAP (red) (B). Loss of opsin staining and up-regulated expression of GFAP were observed in the retinas infected with AAV8-CMV-GFP. (Scale bars, 100 µm.) (C) Quantification of ONL thickness at 1 mm from optic nerve head (ONH). Data are presented as mean ± SD. n = 3–17 per group. One-way ANOVA analysis with Tukey test, **P < 0.01; NS, not significant between the designated group and the uninjected group.
Fig. 1. Retina toxicity is induced by broadly active but not retinal cell-type-specific promoters. (A and B) Wild-type retinas of CD-1 mice were infected at P0 with the indicated viruses at either high (3E9 vg per eye) or low dose (8E8 vg per eye) and harvested at P30 for histology. Retinal cross-sections were stained for short- and medium/long-wavelength opsins (red) (A) and for GFAP (red) (B). Loss of opsin staining and up-regulated expression of GFAP were observed in the retinas infected with AAV8-CMV-GFP. (Scale bars, 100 µm.) (C) Quantification of ONL thickness at 1 mm from optic nerve head (ONH). Data are presented as mean ± SD. n = 3–17 per group. One-way ANOVA analysis with Tukey test, **P < 0.01; NS, not significant between the designated group and the uninjected group.CC BY-NC-ND · PubMed Central
Fig. 2. RPE toxicity is induced by promoters that are active in the RPE. (A) Grading criteria of RPE toxicity, with grade 0 representing completely healthy RPE and grade 5 representing the most severe RPE damage. The typical phenotypes of each grade are described below each image. (Scale bars, 50 μm.) (B) Scatter dot plot of RPE toxicity grades. All viruses were tested at a dose of 8E8 vg per eye, except for AAV8-CAR-GFP (3E9 vg per eye), in CD-1 mice injected at P0 and killed at P30. Data are presented as mean ± SD. n = 2–8 per group. One-way ANOVA analysis with Tukey test, **P < 0.01; NS, not significant between the designated group and the uninjected group.
Fig. 2. RPE toxicity is induced by promoters that are active in the RPE. (A) Grading criteria of RPE toxicity, with grade 0 representing completely healthy RPE and grade 5 representing the most severe RPE damage. The typical phenotypes of each grade are described below each image. (Scale bars, 50 μm.) (B) Scatter dot plot of RPE toxicity grades. All viruses were tested at a dose of 8E8 vg per eye, except for AAV8-CAR-GFP (3E9 vg per eye), in CD-1 mice injected at P0 and killed at P30. Data are presented as mean ± SD. n = 2–8 per group. One-way ANOVA analysis with Tukey test, **P < 0.01; NS, not significant between the designated group and the uninjected group.CC BY-NC-ND · PubMed Central
Fig. 3. RPE and retina damage is dose-dependent. Representative images of RPE and retina of P30 CD-1 mice following infection at P0 with low dose (5E8 vg per eye), medium dose (1E9 vg per eye) and high dose (2E9 vg per eye) of AAV8-CMV-GFP. (A–C) The RPE (labeled with phalloidin staining) and (D–F) photoreceptors (labeled with PNA) from the same areas are shown in upper and lower panels. (Scale bars, 50 µm.)
Fig. 3. RPE and retina damage is dose-dependent. Representative images of RPE and retina of P30 CD-1 mice following infection at P0 with low dose (5E8 vg per eye), medium dose (1E9 vg per eye) and high dose (2E9 vg per eye) of AAV8-CMV-GFP. (A–C) The RPE (labeled with phalloidin staining) and (D–F) photoreceptors (labeled with PNA) from the same areas are shown in upper and lower panels. (Scale bars, 50 µm.)CC BY-NC-ND · PubMed Central
Fig. 4. OCT images of eyes infected by AAV8-CMV-GFP and AAV5-CMV-GFP. (A) Funduscopic images of eyes from C57BL/6J mice infected at P0 with low (L: 8E8 vg per eye) and high (H: 3E9 vg per eye) doses of AAV8-CAR-GFP, AAV8-RedO-GFP + AAV8-Best1-GFP (5:1 ratio), AAV8-CMV-GFP, and AAV5-CMV-GFP viruses. Infected mouse eyes were examined at approximately P30. Green arrow labels the plane where the OCT image was taken. (B) OCT images of the eyes shown in A. White arrowhead, intrusions in subretinal space. BV, blood vessel; INL, inner nuclear layer; IPL, inner plexiform layer; IS/OS, junction of inner and outer segments of photoreceptors; OPL, outer plexiform layer.
Fig. 4. OCT images of eyes infected by AAV8-CMV-GFP and AAV5-CMV-GFP. (A) Funduscopic images of eyes from C57BL/6J mice infected at P0 with low (L: 8E8 vg per eye) and high (H: 3E9 vg per eye) doses of AAV8-CAR-GFP, AAV8-RedO-GFP + AAV8-Best1-GFP (5:1 ratio), AAV8-CMV-GFP, and AAV5-CMV-GFP viruses. Infected mouse eyes were examined at approximately P30. Green arrow labels the plane where the OCT image was taken. (B) OCT images of the eyes shown in A. White arrowhead, intrusions in subretinal space. BV, blood vessel; INL, inner nuclear layer; IPL, inner plexiform layer; IS/OS, junction of inner and outer segments of photoreceptors; OPL, outer plexiform layer.CC BY-NC-ND · PubMed Central
Fig. 5. Toxic AAV causes ERG and optomotor manifestations in C57BL/6J mouse eyes. (A) Representative trace of scotopic ERG (flash intensity: 0.1 cd s/m2, wavelength: 530 nm) of P30 eyes injected at P0 with AAV8-RedO-GFP + AAV8-Best1-GFP (5:1 ratio, RedO+Best1) or AAV8-CMV-GFP (CMV) at low dose or high dose. (B) Statistics of scotopic ERG parameters (a-wave and b-wave amplitude and implicit time) of P30 eyes injected at P0 with RedO+Best1 (low dose: n = 8, high dose: n = 7) and CMV (low dose: n = 10, high dose: n = 8). (C) Representative traces of photopic ERG of P30 eyes injected at P0 with RedO+Best1 and CMV, elicited by 1 (peak), 10 (peak), 100 (xenon), and 1,000 (xenon) cd s/m2 white light flashes with a white light background (bkg) of 30 cd/m2. (D) Ensemble-averaged photopic ERG b-wave amplitude from P30 eyes injected at P0 with RedO+Best1 (low dose: n = 8, high dose: n = 7) and CMV (low dose: n = 10, high dose: n = 8). Significance (P value): CMV (H) vs. RedO+Best1 (H) at 1 (****), 10 (*#), 100 (****), and 1,000 (****) cd s/m2; CMV (L) vs. RedO+Best1 (L) at 1 (**), 10 (*), 100 (NS), and 1,000 (NS) cd s/m2. (Inset) The normalized photopic ERG b-wave intensity–response (r/rmax) curves with I1/2 of RedO+Best1 (low dose: 4.8 cd s/m2, high dose: 5.8 cd s/m2), and CMV (low dose: 9.0 cd s/m2, high dose: 27.0 cd s/m2). (E) Photopic optomotor responses from approximately P35 eyes injected either with RedO+Best1 (low dose: n = 7, high dose: n = 7) or CMV (low dose: n = 13, high dose: n = 7). Acuity: tested at 100% contrast; contrast sensitivity: tested at 0.128 cyc/deg and 1.5-Hz temporal frequency. For all panels, data are presented as mean ± SEM, unpaired Student’s t test *P < 0.05, ***P < 0.001, ****P < 0.0001, *#P < 1 × 10−6, ***#P < 1 × 10−8; NS, not significant. CMV, AAV8-CMV-GFP; H, high dose; L, low dose; RedO+Best1 for AAV8-RedO-GFP +AAV8-Best1-GFP (5:1 ratio).
Fig. 5. Toxic AAV causes ERG and optomotor manifestations in C57BL/6J mouse eyes. (A) Representative trace of scotopic ERG (flash intensity: 0.1 cd s/m2, wavelength: 530 nm) of P30 eyes injected at P0 with AAV8-RedO-GFP + AAV8-Best1-GFP (5:1 ratio, RedO+Best1) or AAV8-CMV-GFP (CMV) at low dose or high dose. (B) Statistics of scotopic ERG parameters (a-wave and b-wave amplitude and implicit time) of P30 eyes injected at P0 with RedO+Best1 (low dose: n = 8, high dose: n = 7) and CMV (low dose: n = 10, high dose: n = 8). (C) Representative traces of photopic ERG of P30 eyes injected at P0 with RedO+Best1 and CMV, elicited by 1 (peak), 10 (peak), 100 (xenon), and 1,000 (xenon) cd s/m2 white light flashes with a white light background (bkg) of 30 cd/m2. (D) Ensemble-averaged photopic ERG b-wave amplitude from P30 eyes injected at P0 with RedO+Best1 (low dose: n = 8, high dose: n = 7) and CMV (low dose: n = 10, high dose: n = 8). Significance (P value): CMV (H) vs. RedO+Best1 (H) at 1 (****), 10 (*#), 100 (****), and 1,000 (****) cd s/m2; CMV (L) vs. RedO+Best1 (L) at 1 (**), 10 (*), 100 (NS), and 1,000 (NS) cd s/m2. (Inset) The normalized photopic ERG b-wave intensity–response (r/rmax) curves with I1/2 of RedO+Best1 (low dose: 4.8 cd s/m2, high dose: 5.8 cd s/m2), and CMV (low dose: 9.0 cd s/m2, high dose: 27.0 cd s/m2). (E) Photopic optomotor responses from approximately P35 eyes injected either with RedO+Best1 (low dose: n = 7, high dose: n = 7) or CMV (low dose: n = 13, high dose: n = 7). Acuity: tested at 100% contrast; contrast sensitivity: tested at 0.128 cyc/deg and 1.5-Hz temporal frequency. For all panels, data are presented as mean ± SEM, unpaired Student’s t test *P < 0.05, ***P < 0.001, ****P < 0.0001, *#P < 1 × 10−6, ***#P < 1 × 10−8; NS, not significant. CMV, AAV8-CMV-GFP; H, high dose; L, low dose; RedO+Best1 for AAV8-RedO-GFP +AAV8-Best1-GFP (5:1 ratio).CC BY-NC-ND · PubMed Central
Fig. 6. Activation of microglia and innate immune response by toxic AAVs. (A) Iba1 staining of retinal sections from P30 eyes of CD-1 mice infected at P0 with the indicated AAV viruses at a dose of 3E9 vg per eye. (Scale bar: 50 μm.) (B) Quantification of displaced Iba1-positive cells by cell layer. High dose (3E9 vg per eye); low dose (8E8 vg per eye). Values are shown as mean ± SD. n = 4 per group. (C) Quantification of microglia in retinas of P20 Cx3cr1-GFP mice by flow cytometry injected with PBS or 3E8 vg per eye AAV8-CMV-TdTomato (n = 3–4 for all groups). Values are shown as mean ± SD. (D) Relative mRNA levels of TNF-α, IL-1β, IL-6, and IFN-γ by qPCR in the retinas of P30 CD-1 mice infected at P0 with the indicated AAV viruses at high dose (3E9 vg per eye). Expression level was normalized to gapdh. Values are shown as mean ± SEM. n = 4–8 per group. One-way ANOVA analysis with Tukey test, **P < 0.01; *P < 0.05; NS, not significant between the designated group and the uninjected group.
Fig. 6. Activation of microglia and innate immune response by toxic AAVs. (A) Iba1 staining of retinal sections from P30 eyes of CD-1 mice infected at P0 with the indicated AAV viruses at a dose of 3E9 vg per eye. (Scale bar: 50 μm.) (B) Quantification of displaced Iba1-positive cells by cell layer. High dose (3E9 vg per eye); low dose (8E8 vg per eye). Values are shown as mean ± SD. n = 4 per group. (C) Quantification of microglia in retinas of P20 Cx3cr1-GFP mice by flow cytometry injected with PBS or 3E8 vg per eye AAV8-CMV-TdTomato (n = 3–4 for all groups). Values are shown as mean ± SD. (D) Relative mRNA levels of TNF-α, IL-1β, IL-6, and IFN-γ by qPCR in the retinas of P30 CD-1 mice infected at P0 with the indicated AAV viruses at high dose (3E9 vg per eye). Expression level was normalized to gapdh. Values are shown as mean ± SEM. n = 4–8 per group. One-way ANOVA analysis with Tukey test, **P < 0.01; *P < 0.05; NS, not significant between the designated group and the uninjected group.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

15 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 92 references

Cited by

See all 249

Metadata

Authors
Xiong, W., Wu, D. M., Xue, Y., Wang, S. K., Chung, M. J., Ji, X., Rana, P., Zhao, S. R., Mai, S., & Cepko, C. L.
Affiliations
  • City University of Hong Kong (HK)
  • Massachusetts Eye and Ear Infirmary (US)
  • Harvard University (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
  • Xiong, Wenjun
  • Cepko, Constance L.
Venue
Proceedings of the National Academy of Sciences
Published
2019-03-04
Volume
116
Issue
12
Pages
5785-5794
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2920682232
Cited by
249
References
92
Citations by year
2026: 24 · 2025: 31 · 2024: 35 · 2023: 33 · 2022: 32 · 2021: 48 · 2020: 39 · 2019: 7
FWCI
18.92
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • CityU Scholars (submittedVersion, cc-by-nc-nd)
Funders
  • Howard Hughes Medical Institute (NA)
  • Astellas Pharma (NA)
  • City University of Hong Kong (9610345)
  • Research Grants Council, University Grants Committee (21105916)
  • National Natural Science Foundation of China (81770937)
  • HHS | NIH | National Eye Institute (K08-EY023993-05, U01 EY025497)
  • Massachusetts Lions Eye Research Fund, Iraty Award (NA)
  • Howard Hughes medical Institute Medical Student Fellowship (NA)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
adeno-associated virus, cis-regulatory sequences, ocular toxicity, retinal inflammation, promoter, retinal pigment epithelium, gene therapy vectors, ocular gene delivery, vector safety
MeSH terms
Dependovirus, Animals, Genetic Vectors, Mice, Inbred C57BL, Photoreceptor Cells, Promoter Regions, Genetic, Retina, Transduction, Genetic, Vision, Ocular, Genetic Therapy, Gene Transfer Techniques, Transgenes, Mice, Retinal Pigment Epithelium

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AAV cis -regulatory sequences are correlated with ocular toxicity. https://app.cochat.ai/papers/10.1073/pnas.1821000116
The paper
Xiong, W., Wu, D. M., Xue, Y., Wang, S. K., Chung, M. J., Ji, X., Rana, P., Zhao, S. R., Mai, S., & Cepko, C. L. (2019). AAV cis -regulatory sequences are correlated with ocular toxicity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1821000116

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.